T&L Biotechnology specializes in the development and production of a range of biotechnological products, particularly focusing on recombinant proteins, monoclonal antibodies, and cell separation technologies. Their offerings include various recombinant human proteins such as TNFα, bFGF, and EGF, which play critical roles in cell signaling and growth. Additionally, the company provides monoclonal antibodies targeting specific human cell markers, which are essential for research and therapeutic applications. Their cell separation technologies utilize magnetic beads, such as the ActSep® and NanoSep™ series, designed for the efficient isolation and activation of T cells and other immune cells, ensuring high stability and separation efficiency.

In addition to their product line, T&L Biotechnology offers customized services, including GMP protein expression and purification, protein characterization, and gene editing services. Their serum-free media and cell culture kits, such as the AMMS® series, are tailored for various cell types, including mesenchymal stem cells and natural killer cells, promoting optimal growth conditions without animal components. The company emphasizes the importance of quality and safety in their products, providing both RUO (Research Use Only) and GMP (Good Manufacturing Practice) grade options to meet the diverse needs of researchers and clinicians in the biomedicine field.

United States

T&L Biotechnology

California - South

California

Antibodies

Biologics

Cell Therapies

Gene Editing/CRISPR

Gene Therapy

Stem Cells

Vendor

T&L Biotechnology

Company Details